Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.32 USD | -4.32% | -6.17% | -47.48% |
May. 09 | Barclays Adjusts Editas Medicine Price Target to $9 From $11, Maintains Equal Weight Rating | MT |
May. 09 | Morgan Stanley Upgrades Editas Medicine to Equal-Weight From Underweight | MT |
Financials (USD)
Sales 2024 * | 34.36M | Sales 2025 * | 24.79M | Capitalization | 438M |
---|---|---|---|---|---|
Net income 2024 * | -229M | Net income 2025 * | -247M | EV / Sales 2024 * | 6.01 x |
Net cash position 2024 * | 231M | Net cash position 2025 * | 95.1M | EV / Sales 2025 * | 13.8 x |
P/E ratio 2024 * |
-1.92
x | P/E ratio 2025 * |
-2.03
x | Employees | 265 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.68% |
Latest transcript on Editas Medicine, Inc.
1 day | -4.32% | ||
1 week | -6.17% | ||
Current month | +2.11% | ||
1 month | -19.76% | ||
3 months | -28.59% | ||
6 months | -30.64% | ||
Current year | -47.48% |
Managers | Title | Age | Since |
---|---|---|---|
Gilmore O’Neill
CEO | Chief Executive Officer | 59 | 22-05-31 |
Erick Lucera
DFI | Director of Finance/CFO | 57 | 23-05-16 |
Linda Burkly
CTO | Chief Tech/Sci/R&D Officer | - | 23-07-23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Emma Reeve
CHM | Chairman | 63 | 21-09-02 |
David Scadden
BRD | Director/Board Member | 71 | 19-02-05 |
Akshay Vaishnaw
BRD | Director/Board Member | 61 | 16-07-27 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
4.83% | 2 M€ | -25.75% | ||
0.13% | 2 M€ | -.--% | ||
0.09% | 0 M€ | 0.00% | - | |
0.06% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 5.32 | -4.32% | 1,637,650 |
24-05-09 | 5.56 | +10.43% | 2,718,539 |
24-05-08 | 5.035 | -11.36% | 4,346,916 |
24-05-07 | 5.68 | +0.35% | 1,567,154 |
24-05-06 | 5.66 | -0.18% | 1,492,893 |
Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-47.48% | 438M | |
+17.96% | 44.96B | |
+48.77% | 41.85B | |
+1.17% | 42.65B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- EDIT Stock